ProfileGDS4718 / 204320_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 10% 22% 41% 18% 13% 20% 56% 19% 14% 19% 10% 23% 54% 69% 24% 22% 23% 87% 74% 96% 21% 22% 10% 19% 17% 67% 21% 80% 13% 17% 22% 83% 25% 11% 93% 68% 27% 27% 22% 24% 20% 30% 97% 68% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.7988910
GSM549102patient 115, normal, homogenized [OPG study]4.2320122
GSM549104patient 119, normal, homogenized [OPG study]5.0222641
GSM549108patient 138, normal, homogenized [OPG study]4.111618
GSM549119patient 077, normal, homogenized [OPG study]3.9053413
GSM549133patient 032, cancer, homogenized [OPG study]4.0851820
GSM549139patient 042, cancer, homogenized [OPG study]5.8282956
GSM549099patient 107, normal, homogenized [OPG study]4.1308419
GSM549109patient 139, normal, homogenized [OPG study]3.9665314
GSM549110patient 046, normal, homogenized [OPG study]4.1123119
GSM549114patient 063, normal, homogenized [OPG study]3.7520510
GSM549122patient 082, normal, homogenized [OPG study]4.2610723
GSM549134patient 033, cancer, homogenized [OPG study]5.7396954
GSM549136patient 036, cancer, homogenized [OPG study]6.8625569
GSM549140patient 044, cancer, homogenized [OPG study]4.2649824
GSM549111patient 047, normal, homogenized [OPG study]4.205722
GSM549113patient 057, normal, homogenized [OPG study]4.1931423
GSM549132patient 031, cancer, homogenized [OPG study]8.6968887
GSM549137patient 038, cancer, homogenized [OPG study]7.2863774
GSM549142patient 047, cancer, homogenized [OPG study]9.8793296
GSM549100patient 110, normal, homogenized [OPG study]4.208321
GSM549107patient 135, normal, homogenized [OPG study]4.1872522
GSM549115patient 068, normal, homogenized [OPG study]3.7599410
GSM549116patient 072, normal, homogenized [OPG study]4.0857619
GSM549120patient 078, normal, homogenized [OPG study]4.0412917
GSM549131patient 030, cancer, homogenized [OPG study]6.6273467
GSM549118patient 074, normal, homogenized [OPG study]4.1959321
GSM549129patient 027, cancer, homogenized [OPG study]7.8749980
GSM549123patient 088, normal, homogenized [OPG study]3.8860813
GSM549124patient 006, cancer, homogenized [OPG study]4.0656417
GSM549126patient 015, cancer, homogenized [OPG study]4.2253122
GSM549128patient 025, cancer, homogenized [OPG study]8.3052483
GSM549103patient 117, normal, homogenized [OPG study]4.3895825
GSM549117patient 073, normal, homogenized [OPG study]3.8145511
GSM549138patient 041, cancer, homogenized [OPG study]9.6610593
GSM549141patient 045, cancer, homogenized [OPG study]6.7402968
GSM549130patient 028, cancer, homogenized [OPG study]4.4405527
GSM549101patient 111, normal, homogenized [OPG study]4.4321327
GSM549105patient 128, normal, homogenized [OPG study]4.2398322
GSM549106patient 134, normal, homogenized [OPG study]4.2520424
GSM549112patient 048, normal, homogenized [OPG study]4.130920
GSM549125patient 011, cancer, homogenized [OPG study]4.5441330
GSM549127patient 024, cancer, homogenized [OPG study]10.865297
GSM549135patient 035, cancer, homogenized [OPG study]6.776968